Mehta Vimal
SEC insider (Form 3/4/5 filer). CIK 0001733369. CEO and President at BioXcel Therapeutics, Inc. (BTAI). 27 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in NEW HAVEN, CT.
Companies Mehta Vimal has filed insider reports for
- BioXcel Therapeutics, Inc. (BTAI): Director, Officer, CEO and President
Mehta Vimal
CIK: 0001733369
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BioXcel Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Jun 15, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect219 shares- - May 20, 2026BTAI
BioXcel Therapeutics, Inc.
SaleDirect19.4K shares at avg. $1.09$21K - May 4, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect49.8K shares- - May 1, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect18K shares- - Mar 15, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect219 shares- - Mar 14, 2026BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect164 shares- - Jan 1, 2026BTAI
BioXcel Therapeutics, Inc.
AwardDirectRestricted Stock Units
199K shares- - Dec 15, 2025BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect219 shares- - Dec 14, 2025BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect164 shares- - Sep 15, 2025BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect219 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 219 | - | $0 | Direct |
| May 20, 2026 | BTAI BioXcel Therapeutics, Inc. | Sale | 19,419 | $1.09 | $21,108 | Direct |
| May 4, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 49,758 | - | $0 | Direct |
| May 1, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 18,000 | - | $0 | Direct |
| Mar 15, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 219 | - | $0 | Direct |
| Mar 14, 2026 | BTAI BioXcel Therapeutics, Inc. | Exercise | 164 | - | $0 | Direct |
| Jan 1, 2026 | BTAI BioXcel Therapeutics, Inc. | Award Restricted Stock Units | 199,032 | - | - | Direct |
| Dec 15, 2025 | BTAI BioXcel Therapeutics, Inc. | Exercise | 219 | - | - | Direct |
| Dec 14, 2025 | BTAI BioXcel Therapeutics, Inc. | Exercise | 164 | - | - | Direct |
| Sep 15, 2025 | BTAI BioXcel Therapeutics, Inc. | Exercise | 219 | - | - | Direct |
1-10 of 27 transactions